Serum and gastric secretion concentrations of serine protease inhibitors alpha-1-antitrypsin and alpha-1-antichymotrypsin have been found to significantly increase during the early stages of similar cancers such as gastric and colorectal cancer [28]. The gene discussed is SERPINA3; the disease is colorectal cancer.